Search

everythinglearnresearchcommunity

for

Search:↓

A shampoo with cannabidiol can significantly reduce scalp inflammation and symptoms in people with mild to moderate psoriasis or seborrheic dermatitis.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

The oral supplement with Pinus pinaster and Grape seed extract, used with sunscreen, effectively and safely improved mild-to-moderate facial melasma.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

The botanical shampoo with Morus alba root extract is safe and effective for treating hair loss.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Rice bran extract caused moderate skin irritation but no eye irritation, while a diluted essence was not irritating to skin and only slightly to guinea pigs.

Xiangdong black goats have moderate genetic diversity, minimal inbreeding, and important genes for reproduction, immunity, and other traits.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Low-dose oral minoxidil effectively treats mild-moderate male hair loss, alone or combined with other therapies.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Nursing students in Turkey have a moderate acceptance of cosmetic surgery, influenced by education, urban background, personal connections to those who had surgery, perception of risk, and desire for awareness training.

Skin diseases have a small to moderate impact on the quality of life of patients in Goa, India.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.